Performance of high-dose omalizumab in chronic urticaria is predicted by initial improvement to standard dose
- PMID: 38906397
- DOI: 10.1016/j.jaip.2024.06.014
Performance of high-dose omalizumab in chronic urticaria is predicted by initial improvement to standard dose
LinkOut - more resources
Full Text Sources